Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

Jeffrey M Jacobson; Robert J Israel; Israel Lowy; Nancy A Ostrow; Linda S Vassilatos; Melanie Barish; Diep N H Tran; Brian M Sullivan; Thomas J Ketas; Tobias J O'Neill

doi:10.1128/AAC.48.2.423-429.2004

Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

Identifier:nobleid.org/w1/20260515/2CF7FF22

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CF7FF22.svg?ark=w1%2F20260515%2F2CF7FF22)](https://nobleid.org/work/w1/20260515/2CF7FF22)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

Identifier:nobleid.org/w1/20260515/2CF7FF22

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CF7FF22.svg?ark=w1%2F20260515%2F2CF7FF22)](https://nobleid.org/work/w1/20260515/2CF7FF22)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work